Detalhe da pesquisa
1.
Non-Small Cell Lung Cancer, Version 4.2024.
J Natl Compr Canc Netw
; 22(4): 249-274, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754467
2.
Mesothelioma: Pleural, Version 1.2024.
J Natl Compr Canc Netw
; 22(2): 72-81, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503043
3.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
J Natl Compr Canc Netw
; 21(4): 340-350, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015337
4.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(9): 961-979, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673108
5.
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(5): 497-530, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545176
6.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668021
7.
New-onset atrial fibrillation incidence and associated outcomes in the medical intensive care unit.
Pacing Clin Electrophysiol
; 44(8): 1380-1386, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173671
8.
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.
Invest New Drugs
; 38(5): 1588-1597, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32246224
9.
UKCAT and medical student selection in the UK - what has changed since 2006?
BMC Med Educ
; 20(1): 292, 2020 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891164
10.
Phase 1 study of ARQ 761, a ß-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis.
Br J Cancer
; 119(8): 928-936, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318513
11.
Beyond 'health and safety' - the challenges facing students asked to work outside of their comfort, qualification level or expertise on medical elective placement.
BMC Med Ethics
; 19(1): 74, 2018 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30029673
12.
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.
Cancer
; 121(18): 3298-306, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26033830
13.
Predictive validity of the UK clinical aptitude test in the final years of medical school: a prospective cohort study.
BMC Med Educ
; 14: 88, 2014 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24762134
14.
Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC.
JTO Clin Res Rep
; 5(5): 100670, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746048
15.
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.
Front Immunol
; 15: 1351739, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38690281
16.
The UKCAT-12 study: educational attainment, aptitude test performance, demographic and socio-economic contextual factors as predictors of first year outcome in a cross-sectional collaborative study of 12 UK medical schools.
BMC Med
; 11: 244, 2013 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24229380
17.
Construct-level predictive validity of educational attainment and intellectual aptitude tests in medical student selection: meta-regression of six UK longitudinal studies.
BMC Med
; 11: 243, 2013 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24229353
18.
Predictive validity of the Dundee multiple mini-interview.
Med Educ
; 47(7): 717-25, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23746161
19.
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer.
Lung Cancer
; 182: 107291, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423058
20.
A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2.
EClinicalMedicine
; 66: 102317, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38192592